Scholars Central

Conference abstractPublished 2017

Using nanocarriers against synucleinopathies

Authors: D Morshedi

National Institute of Genetic Engineering and Biotechnology, Iran

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

α-Synuclein (α-Syn) is a protein present in the brains of a range of neurodegenerative disordered patients as plaque-like compact structures in the form of amyloid fibrils. There is a strong relationship between α-Syn amyloid fibrillation and the pathology of the neurodegenerative disorders such as Parkinson’s disease. There is a serious effort to apply the compounds, known as small molecules, with inhibitory effects on the different steps of α-SN fibrillation and its related neurotoxicity. However, the small molecules can possess some problems like high hydrophobicity/low solubility in physiological fluids, instability, and difficulty in passing across blood brain barrier (BBB). In this respect, employing of nanocarriers has been pointed because of a lot of advantages i.e., biocompatibility, easy surface modification, low immunogenicity, protecting cargo against enzymatic degradation. In this regard, we used three different nanocarriers including serum albumin nanoparticles (SA- NPs), mesoporous silica nanoparticles (MS-NPs) and neutral charged nanoliposomes (NC-NLPs). We found that each kind of nanocarrier possess specific characters when applying for loading drugs or treating α-Syn or neuronal cells. SA-NPs with a moderate drug loading efficiency (DLE) for polyphenols, showed some inducing effect on α-Syn fibrillation when treating with bare SA-NPs. Although MS-NPs with similar DLE did not show inducing effect on α-Syn fibrillation, they had a small neurotoxicity effect. On the other hand, NC-NLPs had high DLE for polyphenols and also, they did not indicate any considerable induction on the α-Syn fibrillation or any neurotoxicity effects. It seems that NC-NLPs have more potential for using regarding synucleinopathies treating than the two other NPs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Nanomaterials & Molecular Nanotechnology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanomaterials & Molecular Nanotechnology
  • SubjectNanotechnology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “D Morshedi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels